XML 54 R22.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2024
Income Tax Disclosure [Abstract] |
Income Taxes | Income Taxes (Loss) income before income taxes was derived from the following sources:
| Year Ended December 31,
| 2024 |  | 2023 |  | 2022
| (Dollars in thousands)
U.S. | $ | (79,339) |  |  | $ | (111,821) |  |  | $ | 55,107 |
Foreign | (73,929) |  |  | (161,943) |  |  | 397,211 |
(Loss) income before income taxes | $ | (153,268) |  |  | $ | (273,764) |  |  | $ | 452,318 |
Income tax (benefit) expense consisted of the following:
| Year Ended December 31, |
| 2024 |  | 2023 |  | 2022
| (Dollars in thousands) |
U.S. income taxes: |  |  |  |  |  |
Current | $ | 153 |  |  | $ | (129) |  |  | $ | 3,590 |  |
Deferred | (17,930) |  |  | (12,643) |  |  | 13,302 |  |
| (17,777) |  |  | (12,772) |  |  | 16,892 |  |
Foreign income taxes: |  |  |  |  |  |
Current | 5,378 |  |  | 9,738 |  |  | 48,744 |  |
Deferred | (9,704) |  |  | (15,480) |  |  | 3,720 |  |
| (4,326) |  |  | (5,742) |  |  | 52,464 |  |
Income tax (benefit) expense | $ | (22,103) |  |  | $ | (18,514) |  |  | $ | 69,356 |  |
A reconciliation of income taxes at the U.S. statutory rate to income tax (benefit) expense follows:
| Year Ended December 31,
| 2024 |  | 2023 |  | 2022
| (Dollars in thousands)
Tax at statutory U.S. federal rate | $ | (32,190) |  |  | $ | (57,490) |  |  | $ | 94,987 |
Impact of U.S. Tax Cuts and Jobs Act of 2017 - GILTI | 195 |  |  | 1,041 |  |  | 38,153 |
Impact of Tax Receivable Agreement | (26) |  |  | 91 |  |  | (39) |
Valuation allowance | 10,396 |  |  | (282) |  |  | (1,259) |
State taxes, net of federal tax benefit | (10,054) |  |  | 818 |  |  | 2,182 |
U.S. tax impact of foreign earnings (net of foreign tax credits) | 587 |  |  | 311 |  |  | 348 |
Establishment/resolution of uncertain tax positions | — |  |  | (36) |  |  | (40) |
Adjustment for foreign income taxed at different rates | 11,476 |  |  | 16,666 |  |  | (25,656) |
Foreign tax credits | — |  |  | (2,534) |  |  | (34,264) |
Change-in-Control-related compensation | — |  |  | — |  |  | (1,432) |
Impact of non-deductible goodwill impairment | — |  |  | 24,570 |  |  | — |
Other | (2,487) |  |  | (1,669) |  |  | (3,624) |
Income tax (benefit) expense | $ | (22,103) |  |  | $ | (18,514) |  |  | $ | 69,356 |
The tax effects of temporary differences that give rise to significant components of the deferred tax assets and deferred tax liabilities at December 31, 2024 and 2023 are set forth in the following table:
| December 31,
| 2024 |  | 2023
| (Dollars in thousands)
Deferred tax assets: |  |  |
Post-employment and other employee benefits | $ | 15,240 |  |  | $ | 18,088 |
Foreign tax credit and other carryforwards | 81,682 |  |  | 40,172 |
Capitalized research and experimental costs | 212 |  |  | 212 |
Environmental reserves | — |  |  | 1,058 |
Inventory adjustments | 4,936 |  |  | 7,710 |
Long-term contract option amortization | 845 |  |  | 881 |
Other | 4,406 |  |  | 1,198 |
Total gross deferred tax assets | 107,321 |  |  | 69,319 |
Less: valuation allowance | (19,308) |  |  | (8,956) |
Total deferred tax assets | 88,013 |  |  | 60,363 |
Deferred tax liabilities: |  |  |
Fixed assets | $ | 50,247 |  |  | $ | 51,474 |
Goodwill and acquired intangibles | 6,676 |  |  | 6,418 |
Mark-to-market hedges | — |  |  | 1,403 |
Other | 1,922 |  |  | 2,732 |
Total deferred tax liabilities | 58,845 |  |  | 62,027 |
Net deferred tax asset (liability) | $ | 29,168 |  |  | $ | (1,664) |
At each reporting period, the Company assesses the need for valuation allowances against deferred tax assets and whether it is more likely than not that deferred tax benefits will be realized in each jurisdiction. Consideration is given to all available evidence, both positive and negative, in assessing the need for a valuation allowance. Examples of positive evidence include a strong earnings history, an event or events that would increase the Company's taxable income or reduce expenses, or tax planning strategies that would create the ability to realize deferred tax assets. Examples of negative evidence include cumulative losses in recent years or a history of tax attributes expiring unused. In circumstances where the negative evidence outweighs the positive evidence, the Company has established or maintained valuation allowances on the jurisdiction’s net deferred tax assets. However, the recognition of the valuation allowance does not limit the Company's ability to utilize these tax assets on a tax return in the future should taxable income be realized in sufficient amount to realize the assets. As of December 31, 2024, we had a valuation allowance of $19.3 million against certain deferred tax assets. Our losses in certain tax jurisdictions in recent periods represented sufficient negative evidence to require a full valuation allowance. However, our U.S. losses in recent periods and the potential for U.S. losses in 2025 may lead to a cumulative U.S. loss and may represent sufficient negative evidence to require a full valuation allowance on U.S. DTAs, which would materially increase our expenses in the period the allowance is recognized and materially adversely affect our financial condition and results of operations. If cumulative losses are incurred, we will evaluate additional evidence such as our projections for growth and market recovery to determine if a valuation allowance is required. We also have a partial valuation allowance related to certain U.S. state net operating and capital losses where realizability is unlikely due to discontinued operations or the ability of our U.S. subsidiaries to generate capital gains. Until we determine that we will generate sufficient jurisdictional taxable income to realize our net operating losses and deferred tax assets, we continue to maintain a valuation allowance. Valuation allowance activity for the years ended December 31, 2024, 2023 and 2022 is as follows:
| (Dollars in thousands)
Balance as of December 31, 2021 | $ | 10,550 |
Credited to income | (1,259) |
Translation adjustment | (22) |
Balance as of December 31, 2022 | $ | 9,269 |
Credited to income | (268) |
Translation adjustment | (45) |
Balance as of December 31, 2023 | $ | 8,956 |
Charged to income | 10,396 |
Translation adjustment | (44) |
Balance as of December 31, 2024 | $ | 19,308 |
The increase in the valuation allowance in 2024 was primarily attributable to generating additional state net operating and capital losses during the year that we may not be able to utilize. The reduction in the valuation allowance in 2023 resulted primarily from changes in expected future utilization, state law changes and expiration of U.S. state NOL carryforwards during the year. As of December 31, 2024, the Company had a total foreign tax credit carryforward of $4.5 million. These tax credit carryforwards begin to expire in 2027. In addition, the Company had state net operating and capital loss carryforwards of $335.2 million (net of federal benefit), which can be carried forward from five to 20 years. These state carryforwards resulted in a deferred tax asset of $21.6 million as of December 31, 2024. The Company also has U.S. state tax credits of $0.2 million as of December 31, 2024. The Company's U.S. interest limitations and foreign loss carryforwards on a gross basis were $126.9 million and $127.6 million, respectively, as of December 31, 2024. These carryforwards do not expire. As of December 31, 2024 and 2023, the Company had no unrecognized tax benefits. No material amounts of accrued interest or penalties have been recorded as of December 31, 2024 or 2023. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| (Dollars in thousands)
Balance as of December 31, 2022 | $ | 36 |
Lapse of statute of limitations | (36) |
Foreign currency impact | — |
Balance as of December 31, 2023 | $ | — |
Lapse of statute of limitations | — |
Foreign currency impact | — |
Balance as of December 31, 2024 | $ | — |
We do not expect there will be new unrecognized tax benefits within 12 months. The Company files income tax returns in the U.S. federal jurisdiction, and various state and foreign jurisdictions. All U.S. federal tax years prior to 2021 are generally closed by statute or have been audited and settled with the applicable domestic tax authorities. Other jurisdictions are generally closed for years prior to 2019. As of December 31, 2024, the Company has accumulated undistributed earnings generated by its foreign subsidiaries of approximately $1.0 billion. Because $1.0 billion of such earnings have previously been subject to taxation by way of the transition tax on foreign earnings required by the Tax Cuts and Jobs Act of 2017, as well as the current and previous years’ GILTI inclusion, any additional taxes due with respect to such earnings or the excess of the amount for financial reporting over the tax basis of GrafTech's foreign investments would generally be limited to foreign withholding and state taxes. The Company intends, however, to indefinitely reinvest these earnings and expect future U.S. cash generation to be sufficient to meet future U.S. cash needs.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration